Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


False Claims Act Update Finds More Clarity On 'Escobar'

Executive Summary

Courts have been busy with False Claims Act-related cases in the first half of 2018 despite a lack of device-specific settlements, new analysis from law firm Gibson Dunn shows. Of particular interest: New rulings that show courts settling on a unified interpretation of the Supreme Court’s 2017 Escobar ruling.

You may also be interested in...

Biden Admin Promises More ‘Aggressive’ Approach To False Claims Act Enforcement, Lawyers Say

Manufacturers may see a more forceful approach toward False Claims Act enforcement under the new administration, attorneys say.

DOJ Issues New FCA, Corporate Compliance Guidance Documents

Department of Justice attorneys are now working with new guidance on how to evaluate corporate compliance programs, as well as how to factor in cooperation credit in False Claims Act cases.

'Escobar' Conundrum: 2017's Biggest Story In Medtech False-Claims Enforcement

A Supreme Court decision that established a new standard in False Claims Act cases was key to FCA enforcement in 2017, when FCA enforcement remained a priority under the Trump administration.


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts